|
ClinicalTrials.gov: diabetes | received in the last 14 days
|
-
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Conditions: Type 1 Diabetes; Type 2 Diabetes
Intervention:
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Recruiting - verified May 2012
-
Italian Diabetes and Exercise Study 2
Condition: Type 2 Diabetes
Intervention: Behavioral: Theoretical & practical exercise counseling
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Not yet recruiting - verified May 2012
-
The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Behavioral: Interactive computer game; Behavioral: Convertible PC
Sponsors: Rabin Medical Center; Rabin Medical Center; Intel
Not yet recruiting - verified April 2012
-
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Condition: Diabetic Nephropathy
Interventions: Drug: Repository Corticotropin Injection; Drug: Placebo
Sponsors: Questcor Pharmaceuticals, Inc.; Questcor Pharmaceuticals, Inc.
Active, not recruiting - verified May 2012
-
Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes Mellitus; Atherosclerosis; Dyslipidemia
Intervention: Other: Statin withdrawal
Sponsors: University of Padova; University of Padova
Not yet recruiting - verified May 2012
-
A Study to Compare LY2963016 to Lantus After a Single Dose to Subjects With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: LY2963016; Drug: Lantus
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified May 2012
-
GooDMoMS: A Multimodel Pregnancy and Postpartum Intervention for Gestational Diabetics
Conditions: Gestational Diabetes Mellitus; Pregnancy
Intervention: Behavioral: lifestyle counseling
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Not yet recruiting - verified May 2012
-
Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo group(once daily); Drug: LC15-0444 50mg qd
Sponsors: LG Life Sciences; LG Life Sciences
Completed - verified May 2012
-
Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
Condition: Hyperlipidemia
Intervention: Drug: Sitagliptin
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Merck Frosst Canada Ltd.
Not yet recruiting - verified April 2012
-
Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LC15-0444 25mg bid; Drug: LC15-0444 50mg qd; Drug: Sitagliptin 100mg qd
Sponsors: LG Life Sciences; LG Life Sciences
Completed - verified May 2012
-
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Conditions: Obesity; Overweight
Interventions: Drug: NB32; Drug: PBO; Behavioral: Weight Management Program
Sponsors: Orexigen Therapeutics, Inc; Orexigen Therapeutics, Inc
Not yet recruiting - verified May 2012
-
Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia
Conditions: Type 2 Diabetes Mellitus; Diabetic Foot Syndrome; Critical Limb Ischemia
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH
Recruiting - verified May 2012
-
Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes Mellitus; Overweight
Intervention: Drug: Liraglutide
Sponsors: Centre Hospitalier Universitaire Dijon; Centre Hospitalier Universitaire Dijon
Completed - verified April 2012
-
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
Conditions: Type 2 Diabetes; Gastric Banding
Interventions: Drug: Liraglutide; Drug: Orlistat; Drug: Liraglutide + Orlistat
Sponsors: East Carolina University; East Carolina University
Not yet recruiting - verified May 2012
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects
Conditions: Diabetes; Diabetes Mellitus, Type 2; Healthy
Interventions: Drug: NNC 0148-0000-0362; Drug: insulin glargine; Drug: placebo; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012
-
Improving Monitoring of Patients Receiving Case Management
Conditions: Multiple Conditions; Coronary Heart Disease; Diabetes; Hypertension; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Southampton; University of Southampton
Not yet recruiting - verified May 2012
-
Veterans Service Organizations and MHV
Conditions: Hypertension; Hyperlipidemia; Coronary Artery Disease; Diabetes Mellitus
Intervention: Other: Education
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; The American Legion, Department of Wisconsin
Not yet recruiting - verified May 2012
-
Jordan Diabetes Microclinic Project
Condition: Diabetes Mellitus, Type II
Intervention: Behavioral: Microclinic
Sponsors: Microclinic International; Microclinic International; Ministry of Health, Jordan; Royal Health Awareness Society (RHAS), Jordan
Active, not recruiting - verified May 2012
-
Lifestyle Therapy for Youth With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Behavioral: Lifestyle Counselling
Sponsors: University of Manitoba; University of Manitoba; Manitoba Institute of Child Health
Not yet recruiting - verified May 2012
-
Cocoa Extract-enriched Meals and Cardiovascular Risk in Older Population
Condition: Cardiovascular Risk Factors
Intervention: Dietary Supplement: Cocoa extract
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; University of Navarra
Active, not recruiting - verified May 2012
-
Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast 500; Drug: Placebo
Sponsors: Spanish Research Center for Respiratory Diseases; Spanish Research Center for Respiratory Diseases
Not yet recruiting - verified May 2012
-
Intervention With Lupin Protein-enriched Foods in Hypercholesterolemic Subjects
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Fabricated foods with lupin protein; Dietary Supplement: Mannitol; Dietary Supplement: Arginine; Dietary Supplement: Fabricated foods with milk protein
Sponsors: University of Jena; University of Jena; German Federal Ministry of Education and Research
Not yet recruiting - verified May 2012
-
Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified April 2012
-
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
Conditions: Coronary Artery Disease; Diabetes Mellitus, Type 2
Interventions: Drug: Liraglutide; Drug: Placebo
Sponsors: Haugaard, Steen Bendix, M.D., DMSc; Haugaard, Steen Bendix, M.D., DMSc
Recruiting - verified May 2012
-
Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide (AVE0010); Drug: liraglutide
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012
-
Metformin in Pregnancy in Women With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Completed - verified May 2012
-
Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards
Condition: Diabetes Mellitus Type 2
Interventions: Drug: regular insulin; Drug: Insulin glulisine, Insulin glargine
Sponsors: HaEmek Medical Center, Israel; HaEmek Medical Center, Israel
Not yet recruiting - verified May 2012
-
Testing the Effect of the InsuPad Device in Daily Life Conditions
Conditions: Diabetics Mellitus Type 1; Diabetes Mellitus Type 2
Intervention: Device: InsuPad
Sponsors: Insuline Medical Ltd.; Insuline Medical Ltd.
Not yet recruiting - verified May 2012
-
Melatonin for Prevention of Metabolic Side Effects of Olanzapine
Conditions: Schizophrenia; Schizophreniform Disorder; Brief Psychotic Disorder; Substance Induced Psychosis
Interventions: Drug: Melatonin; Drug: Placebo
Sponsors: Guilan University of Medical Sciences; Guilan University of Medical Sciences
Recruiting - verified May 2012
-
Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Pioglitazone
Sponsors: Tehran University of Medical Sciences; Tehran University of Medical Sciences
Completed - verified May 2012
|
